Halozyme Therapeutics
HALO
New Fortress Energy
NFE
DexCom
DXCM
4
YETI Holdings
YETI
5
Teradata Corp
TDC
(FY)Feb 1, 2025 | (Q4)Feb 1, 2025 | (Q3)Nov 2, 2024 | (Q2)Aug 3, 2024 | (Q1)May 4, 2024 | (FY)Feb 3, 2024 | (Q4)Feb 3, 2024 | (Q3)Oct 28, 2023 | (Q2)Jul 29, 2023 | (Q1)Apr 29, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 1,214.34%131.66M | 228.61%53.86M | 202.91%36.01M | 134.68%18.12M | 126.42%23.67M | 88.53%-11.82M | -857.65%-41.88M | 192.25%11.89M | 120.88%7.72M | 121.43%10.45M |
Net income from continuing operations | 45.97%-154.91M | 90.12%-11.2M | 16.97%-37.81M | 17.27%-49.61M | 17.05%-56.29M | -15.89%-286.73M | -111.52%-113.37M | 22.24%-45.53M | 6.71%-59.97M | 4.41%-67.86M |
Depreciation and amortization | 33.00%20.65M | 2.50%4.8M | 85.33%6.76M | 24.91%4.63M | 27.87%4.46M | 31.93%15.53M | 37.13%4.69M | 9.00%3.65M | 40.23%3.71M | 47.63%3.48M |
Other non cash items | -70.58%5.3M | -120.61%-2.31M | -7.47%14.18M | -20.35%-7.91M | 168.42%1.33M | 138.59%18M | 255.04%11.19M | 3,274.89%15.32M | -958.82%-6.57M | -161.27%-1.94M |
Change In working capital | -109.22%-1.95M | 32.13%-3.33M | 12.51%-7.54M | -168.86%-4.6M | -51.82%13.51M | 144.14%21.19M | -261.55%-4.91M | -134.66%-8.61M | 132.64%6.67M | 204.09%28.04M |
-Change in receivables | -62.71%-75.53M | -4.17%-52.34M | -3.02%-3.03M | -156.29%-36.02M | -23.82%15.86M | 2.20%-46.42M | -47.05%-50.24M | 80.29%-2.94M | -318.69%-14.06M | 534.70%20.82M |
-Change in inventory | -222.28%-22.42M | -145.94%-2.24M | 66.74%-1.78M | -195.29%-10.13M | -201.27%-8.27M | 344.30%18.33M | 23.79%4.87M | 2.02%-5.34M | 262.10%10.64M | 191.52%8.17M |
-Change in prepaid assets | 76.32%-6.89M | -104.54%-23.78M | 122.28%3.94M | 534.67%9.03M | 433.50%3.93M | -157.47%-29.08M | -94.03%-11.63M | -640.83%-17.69M | 1,592.86%1.42M | 60.65%-1.18M |
-Change in payables and accrued expense | 40.18%37.28M | 90.56%51.07M | -334.27%-11.81M | 135.65%7.69M | -13.55%-9.66M | 97.23%26.6M | 17.13%26.8M | -81.87%5.04M | 112.09%3.26M | 16.82%-8.51M |
-Change in other current assets | 771.91%4.44M | 1,394.21%3.62M | -7.69%-112K | 482.10%619K | -40.90%315K | 127.34%509K | 170.76%242K | 93.46%-104K | 94.46%-162K | -82.19%533K |
-Change in other working capital | 19.33%61.16M | -18.83%20.34M | -57.68%5.26M | 334.83%24.23M | 38.13%11.34M | 673.95%51.25M | 49.75%25.05M | 274.13%12.42M | 42,761.54%5.57M | 374.70%8.21M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 1,214.34%131.66M | 228.61%53.86M | 202.91%36.01M | 134.68%18.12M | 126.42%23.67M | 88.53%-11.82M | -857.65%-41.88M | 192.25%11.89M | 120.88%7.72M | 121.43%10.45M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 15.33%-66.62M | 101.13%482K | -2,232.30%-33.87M | -115.22%-36.29M | 117.21%3.05M | 87.55%-78.69M | 82.89%-42.65M | 99.60%-1.45M | -169.26%-16.86M | -66.19%-17.73M |
Net PPE purchase and sale | -84.21%-20.18M | -155.23%-5.35M | -42.35%-4.78M | -66.18%-4.99M | -102.56%-5.06M | 67.05%-10.95M | 65.10%-2.1M | 67.45%-3.36M | 52.03%-3M | 76.57%-2.5M |
Net investment purchase and sale | 31.68%-46.24M | 114.37%5.83M | -1,623.33%-28.99M | -125.95%-31.2M | 153.27%8.11M | 88.70%-67.68M | 83.33%-40.55M | 100.53%1.9M | ---13.81M | ---15.23M |
Net other investing changes | -300.00%-200K | --0 | ---100K | ---- | ---- | -113.09%-50K | --0 | --0 | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 15.33%-66.62M | 101.13%482K | -2,232.30%-33.87M | -115.22%-36.29M | 117.21%3.05M | 87.55%-78.69M | 82.89%-42.65M | 99.60%-1.45M | -169.26%-16.86M | -66.19%-17.73M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 29.07%27.1M | 27.97%11.49M | -55.51%-367K | 24.90%15.67M | 207.96%312K | 47.74%21M | 33.36%8.98M | 55.39%-236K | 28.75%12.54M | 83.33%-289K |
Net issuance payments of debt | 23.31%-1.69M | 55.51%-351K | 20.96%-396K | 4.07%-448K | -10.71%-496K | -69.22%-2.21M | -76.51%-789K | -35.77%-501K | -89.84%-467K | -85.89%-448K |
Proceeds from stock option exercised by employees | 24.12%28.8M | 21.22%11.84M | -86.42%36K | 23.86%16.12M | 408.18%808K | 28.56%23.2M | 36.05%9.77M | 61.59%265K | 24.45%13.01M | -36.14%159K |
Net other financing activities | ---7K | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 29.07%27.1M | 27.97%11.49M | -55.51%-367K | 24.90%15.67M | 207.96%312K | 47.74%21M | 33.36%8.98M | 55.39%-236K | 28.75%12.54M | 83.33%-289K |
Net cash flow | ||||||||||
Beginning cash position | -30.85%154.74M | -21.41%180.59M | -18.82%178.7M | -16.03%181.67M | -30.85%154.74M | -76.30%223.77M | -51.12%229.78M | -74.08%220.12M | -75.50%216.35M | -76.30%223.77M |
Current changes in cash | 232.56%92.14M | 187.14%65.83M | -82.54%1.78M | -173.61%-2.51M | 457.39%27.03M | 90.36%-69.51M | 69.41%-75.55M | 102.69%10.2M | 110.16%3.4M | 87.64%-7.56M |
Effect of exchange rate changes | -327.04%-1.08M | -224.75%-625K | 119.37%105K | -223.66%-460K | -170.55%-103K | 322.12%477K | -14.21%501K | -622.67%-542K | 281.46%372K | 176.44%146K |
End cash Position | 58.85%245.79M | 58.85%245.79M | -21.41%180.59M | -18.82%178.7M | -16.03%181.67M | -30.85%154.74M | -30.85%154.74M | -51.12%229.78M | -74.08%220.12M | -75.50%216.35M |
Free cash flow | 589.64%111.48M | 210.32%48.51M | 266.03%31.24M | 178.31%13.13M | 133.92%18.61M | 83.29%-22.77M | -323.80%-43.97M | 136.79%8.53M | 110.91%4.72M | 113.38%7.96M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |